Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Kabra Drugs Ltd

NSE: KABRADG · BSE: 524322 · Pharmaceuticals & Biotechnology · 28 announcements

Share price
₹18.65
Market cap
₹44.22 Cr
Revenue (annual)
₹92.74 Cr
Net profit (annual)
₹4.96 Cr
P/E (TTM)
5.8×Sector 47.4×
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14:13 IST BSE
Board Meeting Date

Kabra Drugs Board Meeting Date

Aanjaay Industries Limited has scheduled a board meeting for September 2, 2026. The agenda includes approving the Director's Report and fixing details for the upcoming AGM.

17:25 IST BSE
Board Meeting Date

Kabra Drugs Board Meeting Date

Aanjaay Industries Limited will hold a Board Meeting on 12th August 2026. The meeting will consider the unaudited financial results and a Director's resignation.

17:40 IST BSE
Board Meeting Date

Kabra Drugs Board Meeting Date

Kabra Drugs scheduled a board meeting for May 29, 2026, to approve quarterly financial results. The trading window remains closed for designated persons until result announcement.

16:21 IST BSE
Board Meeting Date

Kabra Drugs Board Meeting Date

Kabra Drugs Limited has scheduled a Board Meeting on May 06, 2026. The board will consider pharmaceutical manufacturing expansion through strategic partners and evaluate defense manufacturing opportunities using Artificial Intelligence technologies. The meeting will be held at the company's Chennai corporate office.